ACS Medicinal Chemistry Letters · 2013 · 42 citations · 14 references
PharmacyChemistryMedicinal ChemistryDrug DesignDrug DiscoveryStructure-activity RelationshipsChagas DiseaseChemical Library DesignEnzyme InhibitionLead Compound DesignLead DiscoveryStructure-activity Relationship AnalysisAcute Chagas DiseaseChronic Chagas DiseaseGrowth Inhibition AssaysHigh-throughput Phenotypic ScreeningStereochemical RequirementsTreatment Of TrypanosomiasisTrypanocidal TherapyTrypanosoma Cruzi Infection
A phenotypic high-throughput screen using ∼100,000 compounds prepared using Diversity-Oriented Synthesis yielded stereoisomeric compounds with nanomolar growth-inhibition activity against the parasite Trypanosoma cruzi, the etiological agent of Chagas disease. After evaluating stereochemical dependence on solubility, plasma protein binding and microsomal stability, the SSS analogue (5) was chosen for structure-activity relationship studies. The p-phenoxy benzyl group appended to the secondary amine could be replaced with halobenzyl groups without loss in potency. The exocyclic primary alcohol is not needed for activity but the isonicotinamide substructure is required for activity. Most importantly, these compounds are trypanocidal and hence are attractive as drug leads for both acute and chronic stages of Chagas disease. Analogue (5) was nominated as the molecular libraries probe ML341 and is available through the Molecular Libraries Probe Production Centers Network.
14
Lisa A. Marcaurelle, Eamon Comer, Sivaraman Dandapani et al. · Journal of the American Chemical Society · 2010 · 213 citations · Full text
Oliver Yun, María Angeles Lima, Tom Ellman et al. · PLoS neglected tropical diseases · 2009 · 185 citations · Full text
Veterinary Medicine, Infectious Diseases, Clinical Medicine +16